Associate Professor at Shanxi Bethune Hospital, China
Zhongbiao Nie is a dedicated clinical pharmacist and associate professor currently affiliated with Shanxi Bethune Hospital. With over a decade of experience in clinical pharmacology and research, he has established himself as a diligent contributor in the fields of nephrology, pain management, metabolic health, and pharmacovigilance. His academic curiosity and commitment to evidence-based medicine are reflected in his numerous publications in high-impact journals such as Journal of Pain Research, Diabetology & Metabolic Syndrome, and Medicine (Baltimore). Zhongbiao is also known for his systematic reviews, randomized controlled trials, and bibliometric analyses, showcasing his strong research methodology. His advanced academic training at Zhejiang University Health Science Center and Peking University Health Science Center has added significant value to his expertise. With a consistent record of publication, clinical service, and professional development, Zhongbiao Nie is emerging as a research-oriented healthcare leader in China’s medical community.
Professional Profile
Education🎓
Zhongbiao Nie began his academic journey at Shanxi Medical University, where he earned his Bachelor’s degree in 2008. He then pursued a Master’s degree (MM) at the Shanxi Academy of Traditional Chinese Medicine, graduating in 2011, where he deepened his understanding of integrative medicine and pharmacological principles. His academic trajectory has been marked by a commitment to ongoing development, including advanced studies at two of China’s leading institutions: Zhejiang University Health Science Center (2018–2019) and Peking University Health Science Center (2023–2024). These opportunities allowed him to acquire cutting-edge knowledge in clinical pharmacology, evidence-based medicine, and public health research. This progressive education, rooted in both traditional and modern medical systems, has equipped him with a comprehensive and nuanced approach to pharmaceutical sciences, blending theory, practice, and translational research. His diverse academic background forms the foundation for his effective contribution to multidisciplinary clinical and scientific teams.
Professional Experience📝
Since July 2011, Zhongbiao Nie has served as a clinical pharmacist at Shanxi Bethune Hospital, one of the region’s most prestigious medical institutions. Over the past decade, he has applied his clinical and academic knowledge to improve patient care, particularly in the areas of postoperative analgesia and nephrology-related therapy. His role bridges clinical responsibilities with academic contributions, positioning him as both a frontline healthcare provider and a research practitioner. As an Associate Professor, he is involved in mentoring, drug evaluation, and clinical research. He has also been actively engaged in conducting randomized trials and meta-analyses that have contributed to clinical practice guidelines. His dual role as a researcher and clinician enables him to directly apply innovative therapeutic strategies to patient care, ensuring that his academic insights are grounded in real-world practice. His professional experience reflects a rare and impactful blend of practical service and scientific rigor.
Research Interest🔎
Zhongbiao Nie’s research interests lie at the intersection of clinical pharmacology, nephrology, pain management, and public health. He is particularly focused on evaluating analgesic protocols, such as patient-controlled analgesia (PCA), in postoperative care and investigating the metabolic outcomes of time-restricted eating. His interest in pharmacovigilance is reflected in his studies on delirium-related side effects of gabapentinoids. In recent years, he has also explored bibliometric analysis, identifying global research trends in immunotherapy for diseases like vasculitis and glomerulonephritis. This multidisciplinary engagement allows him to approach healthcare challenges from both clinical and research-based perspectives. He aims to develop interventions that are safe, effective, and tailored to individual patient profiles. By combining traditional Chinese medicine training with modern clinical pharmacology, he is uniquely positioned to contribute to integrated, holistic medical research. His future work will likely involve expanding into large-scale trials and deeper collaborations in public health pharmacotherapy.
Award and Honor🏆
While specific awards and honors are not explicitly detailed in the available profile, Zhongbiao Nie’s appointment as an Associate Professor and his sustained research contributions indicate peer recognition and institutional appreciation for his work. His numerous publications in PubMed-indexed, PMC-hosted, and Scopus-indexed journals like Journal of Pain Research, Medicine (Baltimore), and Human Vaccines & Immunotherapeutics reflect his standing in the academic medical community. The fact that he has been entrusted with research roles and advanced training opportunities at top-tier institutions such as Zhejiang University and Peking University Health Science Centers further signifies professional endorsement of his academic and clinical capabilities. His roles in multi-author, interdisciplinary studies also suggest leadership and recognition at the team and department levels. As his research visibility continues to grow, he is well-positioned to receive formal accolades in the future for innovation and excellence in medical research.
Research Skill🔬
Zhongbiao Nie possesses a diverse and evolving set of research skills that encompass both clinical and analytical methodologies. He is proficient in conducting randomized controlled trials (RCTs), meta-analyses, and pooled cohort analyses, which are crucial for evidence-based medical recommendations. He demonstrates strong competence in systematic literature reviews, data synthesis, and statistical interpretation using real-world datasets. His bibliometric and scientometric analysis skills allow him to identify emerging trends and guide research direction in fields like immunotherapy and psychiatric disorders. In addition, he shows adeptness in using patient data to study adverse drug events, showcasing a commitment to pharmacovigilance and patient safety. His collaborative approach and involvement in multi-author research projects reveal strengths in team coordination, manuscript preparation, and cross-disciplinary thinking. These skills not only strengthen his individual contributions but also make him a valuable asset in academic and clinical research environments.
Conclusion💡
Zhongbiao Nie demonstrates a balanced blend of academic excellence, clinical application, and forward-thinking research. His work in nephrology, pharmacology, and public health showcases both depth and relevance, with a growing publication record in reputable international journals. His continuous pursuit of advanced training at top Chinese universities and consistent research activity over more than a decade reflect his long-term commitment to medical innovation. With strong potential to lead international collaborations and make deeper societal impacts, he is a deserving nominee for the Best Researcher Award and a promising leader in the medical research field.
Publications Top Noted✍️
-
Wang L, Li L, Zhang R, Zhao J, Wei M, Nie Z – 2025
Comparison of disease burden of major depressive disorder in China and globally from 1991 to 2021
Journal of Affective Disorders
DOI: 10.1016/j.jad.2025.119816
-
Nie Z, Zhang R, Guo Y, Wang X, Zhang K, Zhao H – 2025
Comparison of the burden of musculoskeletal disorders between China and worldwide data using the global burden of disease dataset from 1990 to 2021
Annals of Medicine
DOI: 10.1080/07853890.2025.2529578
-
Li R, Zhang R, Jia Y, Nie Z – 2024
A bibliometric analysis from 2004 to 2024 reveals research hotspots and trends in the immunotherapy for vasculitis
Human Vaccines & Immunotherapeutics
DOI: 10.1080/21645515.2024.2407206
-
Zhang R, Li Y, Nie Z – 2024
A bibliometric analysis from 2014 to 2024 reveals research hotspots and trends in the immunotherapy for glomerulonephritis
Human Vaccines & Immunotherapeutics
DOI: 10.1080/21645515.2024.2420446
-
Nie Z, Liang C, Li Z, Han X, Zhang R – 2024
Gabapentinoids-Related Delirium Adverse Events: A Real-World Study from 2004 to 2022 Based on FAERS
Journal of Pain Research
DOI: 10.2147/JPR.S473226
-
Zhang J, Guo Q, Zhang R, Wei M, Nie Z, Raza F – 2024
Gender Differences in Adverse Events of Ketamine Drugs: A Real‐World Study Based on FAERS
Journal of Clinical Pharmacy and Therapeutics
DOI: 10.1155/2024/4898082
-
Zhao Z, Li Y, Wang P, Zhang R, Nie Z – 2023
Research hotspots and trends in the relationship between genetics and major depressive disorder: A scientometric analysis from 2003 to 2023
Medicine (Baltimore)
DOI: 10.1097/MD.0000000000036460
-
Nie Z, Xu J, Cheng Y, Li Z, Zhang R, Zhang W, Zhao L – 2023
Effects of time-restricted eating with different eating windows on human metabolic health: pooled analysis of existing cohorts
Diabetology & Metabolic Syndrome
DOI: 10.1186/s13098-023-01190-y
-
Nie Z, Cui X, Zhang R, Li Z, Lu B, Li S, Cao T, Zhuang P – 2022
Effectiveness of Patient-Controlled Intravenous Analgesia (PCIA) with Sufentanil Background Infusion for Post-Cesarean Analgesia: A Randomized Controlled Trial
Journal of Pain Research
DOI: 10.2147/JPR.S363743
-
Nie ZB, Li ZH, Lu B, Guo YY, Zhang R – 2022
Hydromorphone vs sufentanil in patient-controlled analgesia for postoperative pain management: A meta-analysis
Medicine (Baltimore)
DOI: 10.1097/MD.0000000000028615
